These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 21980365)

  • 1. The haploinsufficient hematopoietic microenvironment is critical to the pathological fracture repair in murine models of neurofibromatosis type 1.
    Wu X; Chen S; He Y; Rhodes SD; Mohammad KS; Li X; Yang X; Jiang L; Nalepa G; Snider P; Robling AG; Clapp DW; Conway SJ; Guise TA; Yang FC
    PLoS One; 2011; 6(9):e24917. PubMed ID: 21980365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperactive transforming growth factor-β1 signaling potentiates skeletal defects in a neurofibromatosis type 1 mouse model.
    Rhodes SD; Wu X; He Y; Chen S; Yang H; Staser KW; Wang J; Zhang P; Jiang C; Yokota H; Dong R; Peng X; Yang X; Murthy S; Azhar M; Mohammad KS; Xu M; Guise TA; Yang FC
    J Bone Miner Res; 2013 Dec; 28(12):2476-89. PubMed ID: 23703870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperactive Ras/MAPK signaling is critical for tibial nonunion fracture in neurofibromin-deficient mice.
    Sharma R; Wu X; Rhodes SD; Chen S; He Y; Yuan J; Li J; Yang X; Li X; Jiang L; Kim ET; Stevenson DA; Viskochil D; Xu M; Yang FC
    Hum Mol Genet; 2013 Dec; 22(23):4818-28. PubMed ID: 23863460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary osteopathy of vertebrae in a neurofibromatosis type 1 murine model.
    Zhang W; Rhodes SD; Zhao L; He Y; Zhang Y; Shen Y; Yang D; Wu X; Li X; Yang X; Park SJ; Chen S; Turner C; Yang FC
    Bone; 2011 Jun; 48(6):1378-87. PubMed ID: 21439418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant Myeloid Differentiation Contributes to the Development of Osteoporosis in Neurofibromatosis Type 1.
    Rhodes SD; Yang FC
    Curr Osteoporos Rep; 2016 Feb; 14(1):10-5. PubMed ID: 26932441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined MEK inhibition and BMP2 treatment promotes osteoblast differentiation and bone healing in Nf1Osx -/- mice.
    de la Croix Ndong J; Stevens DM; Vignaux G; Uppuganti S; Perrien DS; Yang X; Nyman JS; Harth E; Elefteriou F
    J Bone Miner Res; 2015 Jan; 30(1):55-63. PubMed ID: 25043591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacologically targeting beta-catenin for NF1 associated deficiencies in fracture repair.
    Baht GS; Nadesan P; Silkstone D; Alman BA
    Bone; 2017 May; 98():31-36. PubMed ID: 28254468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mice lacking Nf1 in osteochondroprogenitor cells display skeletal dysplasia similar to patients with neurofibromatosis type I.
    Wang W; Nyman JS; Ono K; Stevenson DA; Yang X; Elefteriou F
    Hum Mol Genet; 2011 Oct; 20(20):3910-24. PubMed ID: 21757497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ras dependent paracrine secretion of osteopontin by Nf1+/- osteoblasts promote osteoclast activation in a neurofibromatosis type I murine model.
    Li H; Liu Y; Zhang Q; Jing Y; Chen S; Song Z; Yan J; Li Y; Wu X; Zhang X; Zhang Y; Case J; Yu M; Ingram DA; Yang FC
    Pediatr Res; 2009 Jun; 65(6):613-8. PubMed ID: 19247213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A murine model of neurofibromatosis type 1 tibial pseudarthrosis featuring proliferative fibrous tissue and osteoclast-like cells.
    El-Hoss J; Sullivan K; Cheng T; Yu NY; Bobyn JD; Peacock L; Mikulec K; Baldock P; Alexander IE; Schindeler A; Little DG
    J Bone Miner Res; 2012 Jan; 27(1):68-78. PubMed ID: 21956219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NF1
    Dodd RD; Lee CL; Overton T; Huang W; Eward WC; Luo L; Ma Y; Ingram DR; Torres KE; Cardona DM; Lazar AJ; Kirsch DG
    Cancer Res; 2017 Aug; 77(16):4486-4497. PubMed ID: 28646022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence of perturbations of cell cycle and DNA repair pathways as a consequence of human and murine NF1-haploinsufficiency.
    Pemov A; Park C; Reilly KM; Stewart DR
    BMC Genomics; 2010 Mar; 11():194. PubMed ID: 20307317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The neurofibromatosis type I gene promotes autophagy via mTORC1 signalling pathway to enhance new bone formation after fracture.
    Tan Q; Wu JY; Liu YX; Liu K; Tang J; Ye WH; Zhu GH; Mei HB; Yang G
    J Cell Mol Med; 2020 Oct; 24(19):11524-11534. PubMed ID: 32862562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rac1 mediates the osteoclast gains-in-function induced by haploinsufficiency of Nf1.
    Yan J; Chen S; Zhang Y; Li X; Li Y; Wu X; Yuan J; Robling AG; Kapur R; Chan RJ; Yang FC
    Hum Mol Genet; 2008 Apr; 17(7):936-48. PubMed ID: 18089636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nf1 Haploinsufficiency Alters Myeloid Lineage Commitment and Function, Leading to Deranged Skeletal Homeostasis.
    Rhodes SD; Yang H; Dong R; Menon K; He Y; Li Z; Chen S; Staser KW; Jiang L; Wu X; Yang X; Peng X; Mohammad KS; Guise TA; Xu M; Yang FC
    J Bone Miner Res; 2015 Oct; 30(10):1840-51. PubMed ID: 25917016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurofibromatosis Type 1 and tumorigenesis: molecular mechanisms and therapeutic implications.
    Gottfried ON; Viskochil DH; Couldwell WT
    Neurosurg Focus; 2010 Jan; 28(1):E8. PubMed ID: 20043723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular Dissection of Somatic Skeletal Disease in Neurofibromatosis Type 1.
    Paria N; Khalid A; Shen B; Lemoine B; Chan J; Kidane YH; Oxendine I; Cornelia R; Wise CA; Rios JJ
    J Bone Miner Res; 2023 Feb; 38(2):288-299. PubMed ID: 36459048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The reduced osteogenic potential of Nf1-deficient osteoprogenitors is EGFR-independent.
    Tahaei SE; Couasnay G; Ma Y; Paria N; Gu J; Lemoine BF; Wang X; Rios JJ; Elefteriou F
    Bone; 2018 Jan; 106():103-111. PubMed ID: 29032173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperactive RAS/PI3-K/MAPK Signaling Cascade in Migration and Adhesion of Nf1 Haploinsufficient Mesenchymal Stem/Progenitor Cells.
    Zhou Y; He Y; Sharma R; Xing W; Estwick SA; Wu X; Rhodes SD; Xu M; Yang FC
    Int J Mol Sci; 2015 Jun; 16(6):12345-59. PubMed ID: 26039236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. β-Catenin modulation in neurofibromatosis type 1 bone repair: therapeutic implications.
    Ghadakzadeh S; Kannu P; Whetstone H; Howard A; Alman BA
    FASEB J; 2016 Sep; 30(9):3227-37. PubMed ID: 27306335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.